ArticleEuropean journal of medical research2026
Polygenic risk scores for Crohn's disease risk prediction in a Chinese population: insights from multi-ethnic genome-wide association studies.
Article in European journal of medical research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Crohn's disease (CD) is a chronic inflammatory bowel disease with a complex etiology involving genetic, immune, microbial, and environmental factors. Despite advances in understanding its pathogenesis, accurately predicting CD risk remains challenging, particularly in East Asian populations. In this study, we evaluated the performance of a polygenic risk score (PRS) model to predict CD risk in a Chinese cohort comprising whole-exome sequencing data of 76 CD patients and 552 healthy controls. We calculated PRS by applying causal genetic effect estimated from summary statistics of a public large-scale multi-ethnic genome-wide association study. Our results demonstrated that the PRS model effectively distinguished CD patients from healthy controls, achieving an area under the receiver opperating characteristic curve of 0.75 and an odds ratio of 13 for individuals with a PRS above 2.3. The model also showed consistent performance in independent control data sets of Chinese, East Asian, European, and American ancestries. These findings highlight the potential of PRS derived from multi-ethnic causal effect as a non-invasive tool for CD risk prediction in East Asian populations. However, the moderate predictive accuracy and unexplained variance emphasize the need for larger studies and the integration of additional genetic and environmental factors to refine PRS model further.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.